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Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant, neuromuscular disorder 
characterized by progressive weakness of muscles in the face, shoulder and upper arm. Deletion of integral 
copies of a 3.3 kb repeated unit from the subtelomeric region on chromosome 4q35 has been shown to be 
associated with FSHD. These repeated units which are apparently not transcribed, map very close to the 4q 
telomere and belong to a 3.3 kb repeat family dispersed over heterochromatic regions of the genome. Hence, 
position effect variegation (PEV), inducing allele-specific transcriptional repression of a gene located more 
centromeric, has been postulated as the underlying genetic mechanism of FSHD. This hypothesis has directed 
the search for the FSHD gene to the region centromeric to the repeated units. A CpG island was identified and 
found to be associated with the 5' untranslated region of a novel human gene, FRG1 (FSHD Region Gene 1). This 
evolutionary conserved gene is located about 100 kb proximal to the repeated units and belongs to a multigene 
family with FRG1 related sequences on multiple chromosomes. The mature chromosome 4 FRG1 transcript is 
1042 bp in length and contains nine exons which encode a putative protein of 258 amino acid residues. 
Transcription of FRG1 was detected in several human tissues including placenta, lymphocytes, brain and muscle. 
To investigate a possible PEV mechanism, allele-specific FRG1 steady-state transcript levels were determined 
using RNA-based single-strand conformation polymorphism (SSCP) analysis. A polymorphic fragment contained 
within the first exon of FRG1 was amplified from reverse transcribed RNA from lymphocytes and muscle biopsies 
of patients and controls. No evidence for PEV mediated repression of allelic transcription was obtained in these 
tissues. However, detection of PEV in FSHD patients may require analysis of more specific cell types at particular 
developmental stages.
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) is a clinically 
heterogeneous, autosomal dominant myopathy with an estimated 
prevalence of 1 in 20 000 (1,2). Initially, the facial and 
shoulder-girdle muscles are affected but during progression of the 
disease the upper-arm, abdominal, pelvic-girdle and foot-exten- 
sor muscles can also become involved (1,3).
The FSHD locus has been assigned to the distal long arm of 
chromosome 4 (4q35) by linkage analysis (4,5), with a most 
likely location distal to D4S139 (6- 8). More recently, rearrange­
ments within a polymorphic EcoRI fragment were detected in
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FSHD patients using probe pl3E-ll (D4F104S1) (9). These 
rearrangements were found to be due to deletion of an integral 
number of 3.3 kb tandemly repeated units (D4Z4) (9,10). 
Although these 3.3 kb repeated units contain a double homeobox 
motif ( 11,12), no transcripts derived from this locus could be 
identified (11-14). In addition, fluorescence in situ hybridization 
(FISH) experiments showed that the tandem array of 3.3 kb 
repeats maps very close to the 4q telomere (13,15,16), suggesting 
a probable location of the FSHD gene proximal to the repeated 
units. Recent data suggested that the repeated units are members 
of a 3.3 kb repeat family dispersed over heterochromatic regions
582 Human M olecular Genetics, 1996, Vol. 5, No . 5
of the genome (14). This is supported by FISH results demon- 
strating hybridization of the 3.3 kb repeated unit to the short arms 
of all acrocentric chromosomes as well as to chromosomes i q 12, 
4q35,10qter,and lOcen (13,16). Weak signals were also detected 
on a large heterochromatic region on chromosome 9ql2, and 
chromosome Y. Therefore, considering that the 3.3 kb repeated 
unit may be heterochromatin-associated, deletion of a number of 
these repeated units may lead to position effect variegation (PEV) 
by alteration of the chromosomal structure. Heterochromatiniz- 
ation or extensive chromatin packaging (17) can transcriptionally 
silence a gene by (i) inducing a later replication time point which 
will put the gene at a disadvantage in the competition for 
transcription factors (18), or (ii) generating a more tightly 
condensed structure of the chromatin which itself contributes to 
its transcriptionally silent state (18-20). A classic example of 
heterochromatinization in mammals involves transcriptional 
silencing of genes by X chromosome inactivation (21-23), 
Furthermore, since telomeres have a functional location in the 
nucleus (24), the FSHD associated deletions may also have 
implications for the nuclear organization. PEV leading to reduced 
transcript levels of one allele of a gene has been observed in 
Drosophila, yeast and mammals (17,25), and may affect genes 
over a region of several hundred kb (26). When taken into account 
that the deletion prone EcoRl fragments can be 300 kb in healthy 
individuals and 10 kb in FSHD patients (27), the FSHD-asso- 
ciated deletions of 3.3 kb repeated units may also involve several 
hundred kb. Therefore, the FSHD candidate gene region sub­
jected to several gene identification methods was chosen to 
extend about 150 kb proximal to the 3.3 kb repeats.
Here, we report the isolation and characterization of a novel 
gene cloned from the FSHD region (F R G I). The PEV hypothesis 
was tested by analysis of allele-specific transcription of this gene 
in lymphocytes and muscle tissue of patients and controls.
RESULTS
Isolation and sequence analysis of FRG1  cDNAs
Previous mapping studies (28,29) showed the presence of a CpG 
island located within a 6.5 kb EcoRl fragment of cosmid cT171 
which was isolated from a cosmid library made from YAC 25C2E 
(D4S1093) (28). A total of 6.2 kb of contiguous sequence from this
6.5 kb EcoRl fragment was determined (GenBank accession 
number L76174) by sequencing adjacent Pstl subclones located 
within this fragment. The  CpG island spans a region of 1 kb 
showing a G+C content of 63% and a CpG:GpC ratio of 0.8. A 1.2 
kb Pstl subclone (plOB) encompassing the CpG island (Fig. 1), 
was used as a probe to screen a human skeletal muscle cDNA 
library. A 640 bp cDNA clone (10B7, Fig. 1), was isolated and, 
after sequencing, shown to contain the 3' end of a cDNA. Clone 
10B7 hybridized to a LI kb transcript in total RNA from 
lymphocytes and fetal muscle, and poly-(A)+ RNA from adult 
muscle, fetal brain and placenta (Fig. 2). Subsequently, two cDNA 
clones were obtained by screening a total infant brain cDNA 
library (BS3; 3.5 kb insert), and a fetal brain cDNA library (10B 1;
1.3 kb insert), with probe 10B7 (Fig. 1). These clones were 
sequenced and their unexpectedly large cDNA inserts were shown 
to be due to splicing aberrations and cloning artefacts (see below). 
Additional cDNA fragments were obtained by amplification of 
different cDNA libraries using one of the cDNA library vector-spe­
cific primers flanking the cloning site, in combination with 
10B7-based primers. Two cDNA fragments, PLC2FB22 (700 bp)
and ML8RT3 (780 bp) were amplified from the placenta and 
muscle cDNA library, respectively. By sequence analysis these 
fragments were found to overlap, spanning 913 bp (Fig. 1). To 
determine the transcription start site of the cDNA, two primers at 
the 5' end of the cDNA (lr* and 2r) were designed to perform 5' 
RACE [rapid amplification of cDNA ends (30)] from human brain 
cDNA. The obtained RACE products were sequenced and found 
to start at, or just distal of, position -191 upstream from the putative 
transiation initiation site (Fig. 3b). Subsequently, primers (If and 
9r) were chosen at positions -134 and 801 to perform RT-PCR on 
RNA isolated from a chromosome 4 only cell hybrid, muscle 
tissue, and lymphocytes. In all cases, an identical 935 bp product 
was obtained which is in accordance widi the total transcript length 
of about 1.1 kb detected by Northern blot analysis. Further 
sequence analysis confirmed the identity of these RT-PCR 
products. The complete cDNA sequence of tliis novel human gene, 
named FRG1 (FSHD Region Gene 1), was compiled (GenBank 
accession number L76159); spanning 1042 bp and containing an 
open reading frame of 258 amino acid residues (Fig. 3b). The 
putative translation start site is the first in frame ATG codon located 
191 bp downstream of the 5' end of the transcript, which conforms 
to the Kozak consensus sequence (31). The 3' untranslated region 
is 74 bp and ends with a poly-(A) tail 25 bp downstream of a 
polyadenylation signal at position 821 (Fig. 3b). Nucleotide 
sequence database searches (BLAST-N) identified several highly 
homologous human EST clones: a human HL60 EST clone 
(accession number D 19665), and from the WashU-Merck EST 
Project; accession numbers T41211, T51111, T51019; all being 
96-99% homologous to the 3' end of the cDNA, and R77057; 95% 
homologous to the internal part of the cDNA, Furthermore, a 
mouse EST clone (GEG-123, accession number X71639) showed 
high homology (86%) to the 3' end of the FRGI transcript. 
Southern blot analysis also indicated that FRGI is evolutionarily 
conserved (Fig. 4a). No significant homology to known genes was 
detected in either the nucleotide sequence databases or the protein 
databases (BLAST-P). Protein motif searches gave no indication of 
a possible function for the deduced FRGI protein.
Genomic organization of F R G I
Southern blot analysis revealed that the FRGI cDNA is 
distributed over three EcoRl fragments contained within cosmid 
cTI71 (Fig. 1, Fig. 4b). These EcoRl fragments were subcloned 
and partially sequenced using FRGI cDNA-based primers. The 
1042 bp cDNA sequence was found to be completely identical to 
the genomic sequence and is composed of nine exons (Fig. 1). 
The sequences of the intron-exon boundaries were determined 
and shown to be in accordance with splice site consensus 
sequences (Table 1).
The promoter region of FRGI (Fig. 3a, GenBank accession 
number L76173) coincides with the identified CpG island (see 
above). No TATA or CAAT box motifs were found, but three 
putative Spl binding sites (32) are present at positions -743, -403, 
and -310, which may function as control elements of transcription 
(33). Absence of a TATA box in genes with a 5' CpG island has 
been reported for many housekeeping genes and appears to be 
related to the regulation of widely expressed genes (34).
Chromosomal distribution of F R G I
The 935 bp chromosome 4 FRGI RT-PCR product hybridized to 
eight different human genomic EcoRl fragments with varying
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Figure 1. An ¿ccR I and ///Vzdlll restriction map of cosmid cT171, containing the complete F R G l ,  is shown. The CpG island located within the 6.5 kb £a?R l fragment 
is indicated by the vertically hatched box. Probe p i OB with which cDNA clone 10B7 was identified from the muscle cDNA library, is depicted as a black box above 
the CpG island. On top, the position of cT171 with respect to known loci (D4S139, D4F35S1, D4F104S1, D4Z4, D4Z3) on YAC 25C2E (D4S1093) is shown. Below 
the map, the FRGl intron-exon structure is depicted. The exons (black boxes) are dispersed over three genomic £<%>RI fragments. In the more detailed representation 
of the FRGl structure, exons are shown as numbered boxes. Primers are indicated below the exons. The putative translation initiation site is depicted by the arrow 
on top of exon 1. At the bottom of the figure the different cDNA clones are shown. Clones 10 B 7 ,1 OB 1 and BS3 contain splicing aberrations; skipped exons are indicated 
by A, unspliced introns as black boxes, and truncated exons by dotted lines, Clone 10B7 lacks exons 4,5, and part of exons 1,3, and 6 and probably carries an internal 
exon inversion. Clone 10B1 lacks exons 4 and 5 and is at exon 8 coligated to a non-FRGl like cDNA with a different chromosomal origin (obliquely hatched box). 
Clone BS3 lacks exons 4 and 6 but contains introns I and 8, probably due to differential splicing and the presence of incorrect splice site consensus sequences. The 
cDNA fragments ML8RT3 and PLC2FB22 represent the correctly spliced FRGl cDNA.
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Figure 2 . Northern blot, containing 1 |ig of poly-(A)+ RNA indicated by (+), 
from adult muscle, fetal brain and placenta, and 20 }a,g of total RNA from fetal 
muscle and lymphocytes, hybridized with cDNA clone 10B7. A 1.1 kb 
transcript was detected in all tissues analyzed.
intensities (Fig. 4). Only three of these fragments are derived from 
the chromosome 4q35 region (Fig. 1, Fig. 4b), suggesting the 
presence of multiple FRG l -related sequences in the genome. To 
identify the chromosomal origin of the different members of this 
novel multigene family, the three EcoRl fragments of cosmid 
cT171 containing the FRG l exons were independently used as 
probes for fluorescent in  s i tu  hybridization (FISH) to metaphase
spreads. For each fragment an identical hybridization pattern was 
detected. Hybridization signals were found at chromosome 4q35, 
at three sites in the pericentromeric region of chromosome 9, at 
the short arm of all acrocentric chromosomes (13, 14, 15, 21, 
and 22) and at the centromeric region of chromosome 20 (Fig. 5). 
Subsequent PCR analyses of DNA from a monochromosomal 
somatic cell hybrid mapping panel using several primer combina­
tions, confirmed the chromosomal dispersion of F/?G/-related 
sequences. With most primer combinations, appropriate PCR 
products could be amplified from ceil hybrids containing one of 
the human chromosomes 4, 8, 9, 12, 13, 14, 15, 20, 21, and 22. 
To illustrate this, amplification of a fragment containing part of 
intron 4 and exon 5 using primers 5fl and 5r, is shown in Figure 
6a. The appropriate 320 bp product was detected in somatic cell 
hybrids containing chromosomes 4, 8 , 9, 12, 20, 21 or 22. 
However, this product could not be amplified from cell hybrids 
containing chromosomes 13, 14, or 15, which may be an 
indication for sequence differences or the presence of processed 
F R G l-like pseudogenes. Amplification of the 320 bp fragment 
from cell hybrids containing chromosomes 8 or 12 does not 
correspond to the negative FISH results, suggesting that these 
chromosomes may harbor incomplete F R G l-related sequences 
not detectable by FISH.
Unlike most FRGl primers, primer If derived from the 5' 
untranslated region of F R G l ,  enabled chromosome 4 specific 
amplification of FRGl fragments, when used in several primer 
combinations. For example, using primers If and lrb, a 180 bp 
fragment in exon 1 could only be amplified from DNA of the 
single chromosome 4 cell hybrid (Fig. 6b). In addition, RT-PCR 
analysis of total RNA isolated from somatic cell hybrids specific
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Northern blot analysis of total RNA isolated from lymphocytes demonstrate co-segregation of the with the
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Table 1. Sizes, splice junctions, and primers o f  FRGI  exons
Exon Nucleotide Exon Splice junctions Forward primer Reverse primer
no. position size (bp) 3' splice site 5 ' splice site
1 -1 9 1 * -6 2 253 — GAG/gtggg 1 f: 5 '-TCTACAGAGACGTAGGCTGTCA-3' 1 ra: 5'-CCGGTTCTGGACGAGTATGT-3'
]rl>: 5'-CTTGAGCACGAGCTTGGTAG-3'
2 63-133 71 tgtag/TAA TTG/gtgag 2 f: 5 '-GAAGAAGATGAAGAAACCCAGC-3' 2r: 5'-CAACAATATCAAGCTGGGTTTC-3'
3 134-259 126 tttag/GAA AAG/gtttg 3f: 5'-GCCATTGAAATGGATA AGGG-3' 3r: 5'-TCCATTTCAATGGCTATGGT-3'
4 260-317 58 aatag/TTG CAG/gtgag 4f: 5 '-GCCCTAGTCCTCCAGAGCAG-3' 4n 5'-GGAATCAGATAA'HTGACAGCC-3'
5 318-432 115 tac ag/A AT AAT/gtaag 5 P  S: 5 '-AG ATGGGGTCTCACTGTGTTG-3'
SP : 5'-AGAGAACAATGGGAACCAGTC~3'
5r: 5'-TCTTGGTCCAATTGCATCTG-3'
6 433-537 105 cttag/GGG AAG/gtaat 6f: 5^GGAAAATGGCTTTGTTGGCCTC-3' 6r: 5'-CTTCTATGTCCCCTGCTTCA-3'
7 538-629 92 tc tag/ ATT TGT/gtatg 7f: 5'-CAAGATTAGATCCTGTGCTG-3' 7r: 5 '-TTTCCTTTGTCTTCTTCTGGAA-3'
8 630-740 i l l tacag/AAA CAG/gtagc 8f: 5'-GGCTCGGAAAGATGGATTTT-3' 8r: 5'-AAAATCCATCTTTCCGAGCC-3'
9 741-851 111 aacag/GAG — 9f: 5 '-GAGAGCCAAATTGAAAGCCG-3' 9r: 5'-ATAAGGCAGAAACAAAAATCCC-3'
*Putative transcriptional start site 
^Primer 5 f“ is derived from intron 4 sequence
Southern blot analysis
The 935 bp FRG I RT-PCR product, which was amplified from 
a chromosome 4 only somatic cell hybrid using primers 1 f and 9r, 
was hybridized to Southern blots containing: (i) EcoRl digests of 
total human (2 ¡ng/lane), monkey, sheep, and rat (8 (ig/lane) (‘Zoo 
blot’, Fig. 4a); and (ii) Ec^RI and H indlll digests of total human 
lymphocytes DNA (7 jUg/lane), YAC 25C2E (D4S1093) (1.5 jig/ 
lane), and cosmid cT171 (28) (1.5 ng/lane) (Fig. 4b). Digestions 
with specified restriction enzymes were performed according to 
the manufacturer’s instructions (Pharmacia). Hybridizations 
were performed for 16 h at 65 °C for the Southern blot and at 
57 ° C for the ‘Zoo’ blot, as described (48). The blots were washed 
at 65 °C and to a stringency of 0.3x SSC/0.1% SDS for the 
Southern blot and of Ix  SSC/0,1% SDS for the ‘Zoo’ blot and, 
followed by autoradiography for 16-36 h at -70°C  using Konica 
AX film with an intensifying screen.
Netherlands. A total of 35 cycles (94 °C for 40 s, 60 °C for 60 s and 
72 °C for 90 s) were run in a 50 pi volume containing 2.5 ng of 
cDNA, 1.0 U Ttfiy-DNA-polymerase (Perkin-Elmer), 200 |XM of 
each dNTP, 100 ng of each primer and 5x PCR standard-buffer 
[300 mM Tris-HCl, 75 mM (NH4)2S04, 17.5 mM MgCl2, pH 8.5].
Fluorescent in situ hybridization
Metaphase chromosome spreads from normal human lympho­
cytes were hybridized with the 3 kb, 6.5 kb, and 9.5 kb EcoRl 
fragments of cosmid cT171. Probes were labelled by nick 
translation with biotin 11-dUTP (Sigma) (50). Hybridization, 
washing and staining were performed as previously described (8).
RNA isolation and Northern blot analysis
Total RNA was isolated from various human tissues and somatic 
cell hybrids as previously described by Chomczynski and Sacchi 
(49). Poly-(A)+ RNA was isolated using the PolyATtract mRNA 
Isolation Systems kit (Promega) or purchased from ClonTech. 
Northern blots were prepared containing 20 (tg total RNA or 1 jig 
poly-(A)+ RNA. Hybridizations were performed in a formamide 
hybridization mix (45) for 16 h at 54°C using a -32P labelled 
10B7 as probe. The blots were washed at 65 °C and to a stringency 
of 2x SSC/0.1% SDS, followed by autoradiography for 16-36 h 
at -7 0 °C using Konica AX film with an intensifying screen.
(RT-) PCR analysis
cDNA was synthesized from 5 (ig of total RNA isolated from 
human muscle, human lymphocytes, somatic cell hybrids specific 
for the particular chromosomes, Chinese hamster lung cells (V79) 
and mouse A9 cells, using an oligo-dT primer and the AMV 
Reverse Transcriptase kit from Promega. The primers used for 
(RT-) PCR analyses are indicated in Figure 1 and Table 1. All 
primers were provided by Isogen Bioscience BY, Maarssen, The
Allele-specific analysis of F R G I  steady-state transcript 
levels (RNA-based SSCP)
cDNA of lymphocytes and muscle tissue was primarily amplified 
using primers If and 9r (Fig. 1, Table 1). For the SSCP analysis 
(35,36), PCR products were diluted 1:50 of which subsequently
1 jal was used for secondary amplifications with primer combina­
tions lf/lr51, lf/2r, 2f/6r or 5f/9r (Fig. 1, Table 1) and with 
incorporation of oc-32P labelled dCTP Products were diluted 1:25 
in a formamide loading buffer (1:1 mix of 95% forma- 
mide/20 mM EDTA and 0.1% SDS/ 10 mM EDTA) and 
denatured at 100° C for 10 min. Electrophoresis was performed 
in non-denaturing 0.5x MDE polyacrylamide gels (J.T. Baker) 
and 0 .6x TBE buffer (lx: 0.09 M Tris, 0.09 M Boric acid, 0.002 
M EDTA, adjusted to pH 8.0) using a BRL-S2 vertical gel 
apparatus (Life Technologies, Inc.). Gels of 40 cm were run at 25 
Watt for 3-4 h and subsequently dried at 80° C under vacuum, and 
exposed at -70 °C for 12-24 h to Konica AX film with an 
intensifying screen.
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